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A peptide corresponding to a basic consensus amino acid motif present in both actin-binding proteins and phosphoinositide-specific phospholipases 
C was synthesized and its effect on the activity of a recombinant phospholipase C-b, (PLC/.Id expressed in baculovirus-infected insect cells was 
studied. The peptide markedly and specifically stimulated the activity of the enzyme. This stimulatory effect required a particular primary and/or 
secondary structure of the peptide and occurred without lowering the affinity of the enzyme for Ca*‘. The function of the PLC@, segment 
corresponding to the peptide might be to bind and offer the substrate to the catalytic domain of this enzyme in a more favorable configuration 
or, alternatively, to interact with a hypothetical inhibitory constraint. 
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1. INTRODUCTION 
The phospholipase C (PLC)-catalyzed hydrolysis of 
phosphatidylinositol 4,5_bisphosphate (PtdInsP,) con- 
stitutes a fundamental part of a major transmembrane 
signal transduction pathway [1,2]. A still growing num- 
ber of PLC isoforms has been identified in mammalian 
cells [3,4]. These isoforms present two homology do- 
mains, designated X and Y, which seem to be required 
for their catalytic activity. The mechanism of interac- 
tion with and cleavage of the substrate remains, how- 
ever, essentially unknown. 
It has been suggested that a similar potential 
PtdInsPz binding site exhibiting the amino acid motif 
KXXXKXKK and comprising the carboxyl-terminal- 
most region of the X domain exists in various intracellu- 
lar PLCs [5]. We have studied the effect of a synthetic 
peptide corresponding to the proposed PtdInsP, bind- 
ing site in PLC/12 on the activity of a recombinant 
PLC/3* expressed in Spodoptera frugiperda cells (Sl9 
cells). Our findings show that this peptide markedly and 
specifically stimulates the catalytic activity of this en- 
zyme. 
In addition to its role as a precursor for second mes- 
sengers, PtdInsP, appears to be involved in the regula- 
tion of several actin-binding proteins, namely gelsolin 
[5,6], villin [6], profilin [7,8], gCap39 [9], cofilin [lO,ll], 
destrin [lo] and deoxyribonuclease I [lo]. Potential high 
affinity polyphosphoinositide binding sites have been 
proposed in these proteins, based partially on muta- 
genesis experiments [5]. Furthermore, it has been re- 
ported that synthetic peptides whose sequences corre- 
spond to those binding sites can bind tightly to 
PtdInsP,, compete with the proteins for the binding to 
this phospholipid, and dissociate protein/PtdInsP, com- 
plexes [5,6]. Both the basic character and the particular 
structure of these peptides seem to be required for their 
interaction with the acidic headgroup of PtdInsP, [5,6]. 
2. MATERIALS AND METHODS 
2.1. Materials 
Lysine-phenylalanine (1: 1), and lysine-alanine (1: 1 and 2: 1) random 
copolymers were obtained from Sigma (Deisenhofen, FRG). L-lysine 
trimer, tetramer and pentamer were purchased from Bachem (Hei- 
delberg, FRG). All other materials were from standard vendors or 
from sources previously described [13,141. 
2.2. Peptide synthesis 
The peptide NH,-CGGLPSPEDLRGKILIKNKK-CONH, was 
produced in a fully automated synthesizer employing the Fmoc strat- 
egy. The product was purified by preparative HPLC on a Parcosil 
ProRP Cl8 300-7 reverse-phase column. The purified peptide was 
characterized by analytical HPLC and laser desorption mass spec- 
trometry. The lyophilized peptide was dissolved in 50 mM Tris-HCl, 
pH 7.4, prior to the experiments. The peptide corresponds to amino 
acids 44%464 of PLC#* [12]. The amino-terminal cysteine and two 
glycines were added to facilitate coupling to a carrier protein for 
eventual antibody production. 
*Corresponding author. Fax: (49) 6221 423352. 
Abbreviations: InsP, inositol monophosphate; InsP,, inositol4,5-bis- 
phosphate; InsP,, inositol 1,4,%risphosphate; PLC, phospholipase C; 
PtdInsP,, phosphatidylinositol4,5-bisphosphate; S 9 cells, Spodopteru 
fiugiperdu cells. 
2.3. Production of recombinant phospholipase C 
Spodopterafrugiperda cells (93 cells, Invitrogen) were transfected 
with a 1O:l mixture of transfer vector and a modified baculovirus 
DNA (Baculogold, Pharmingen) [14]. The transfer vector (pVLl393) 
encoded either B-galactosidase (Invitrogen) or a deletion mutant of 
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PLCB, (PLC&t). PLC&t differs from the wild-type PLC/I, isozyme 
in two respects. First, it lacks a carboxyl-terminal region (F819-El166) 
necessary for stimulation by czs subunits [15]. Second, it carries a 
serine-to-alanine replacement in position two due to the introduction 
of an NcoI restriction enzyme site into its cDNA. PLC&t is indistin- 
guishable from wild-type recombinant PLCS, in terms of its interac- 
tion with PtdInsP,, Ca*+, and G-protein By-subunits (P. Schnabel et 
al., in preparation). For production of the recombinant proteins, St9 
cells were maintained and infected exactly as previously described [14]. 
The cells were washed [14] and homogenized by two freeze-thaw cycles 
in hypotonic buffer containing 20 mM Tris-HCl, pH 7.5, 2 mM 
EDTA, 2 &ml soybean trypsin inhibitor, 3 mM benzamidine, 1 PM 
pepstatin, 1 PM leupeptin, 100 PM phenylmethylsulfonyl fluoride. 
After centrifugation at 50,000 x g for 20 min at 4”C, the soluble 
fraction was collected. The expression of PLCS, was verified by SDS- 
PAGE and immunoblotting [16]. 
2.4. Phospholipase C assay 
Phospholipase C activity was assayed using exogenous radiola- 
belled substrate ssentially as previously described [171. In brief, 0.1 pg 
of soluble protein from Sf9 cells was incubated for 30 min at 25°C in 
a volume of 70 ~1 containing 28 PM [3H]PtdInsP, (5 Wmol), 280 PM 
phosphatidylethanolamine, 50 mM Tris-maleate, pH 7.4, 3 mM 
EGTA, 80 mM KCl, 10 mM LiCl, 10 mM 2,3_bisphosphoglycerate, 
1 mM ATP, 1.2 mM sodium deoxycholate, and 1 mM free Ca2’, unless 
otherwise specified. The reaction was terminated by adding 350 ~1 of 
CHCljCH,OH/concentrated HCl(500:500:3, by vol.), vortexing and 
adding 100 ~1 of 1 M HCl containing 5 mM EGTA. Radioactivity 
released into the upper aqueous phase was quantitated by liquid, 
scintillation counting. To adjust the concentration of free Ca” to the 
desired value, the amount of CaCl, to be added to the assay was 
calculated as previously described [17]. In some cases, the relative 
amounts of inositol, glycerophosphoinositol, InsP, InsP, and InsP, 
present in the aqueous phase were quantitated following a previously 
described method [18]. 
2.5. Miscellaneous 
Protein concentrations were determined according to Bradford [19] 
using bovine IgG as standard. All experiments were repeated at least 
twice. Data from representative experiments are shown as means of 
triplicate determinations f SD. 
3. RESULTS 
We initiated our work by studying the effect of a 
peptide corresponding to a previously proposed 
PtdInsP, binding site in PLCsz on PtdInsP, hydrolysis 
by soluble fractions of Sl9 cells expressing PLC&l, a 
deletion mutant of PLCB,. Much to our surprise, the 
peptide markedly stimulated the activity of PLC&l 
(Fig. 1). Half-maximal stimulation was observed at ap- 
proximately 15 ,uM peptide, corresponding to a 
PtdInsPJpeptide molar ratio of approximately 2. The 
stimulatory effect of the peptide, which by itself did not 
exhibit PLC activity, ensued without delay and was 
clearly noticed even at incubation periods as short as 
5 min (data not shown). Additional experiments re- 
vealed that InsP, was the predominant (87%) product 
of peptide-stimulated PtdInsP, hydrolysis and that only 
a minor fraction (8%) appeared as InsP,. Values for 
In@, inositol and glycerophosphoinositol were not sig- 
nificantly different from zero (data not shown). 
Fig. 2 shows that the peptide specifically stimulates 
PLC&t. Thus, 28 ,uM of the peptide led to an approx- 
imately 5-fold stimulation of the soluble PLC activity 
present in cells infected with baculovirus encoding 
PLC&t. In contrast, no PLC activity could be detected 
in soluble preparations of /&galatosidase-baculovirus- 
infected cells, regardless of whether the peptide was 
absent or present in the incubation medium (Fig. 2A). 
PLC activity increased linearly with the amount of sol- 
uble protein present in the incubation (O-O.1 &tube), 
both in the absence or the presence of the peptide. Thus, 
the relative stimulation by the peptide remained con- 
stant within this range of protein concentration (Fig. 
2b). Incubating the soluble fraction of cells expressing 
PLC&l for 10 min at 95°C completely abolished PLC 
activity, either in the absence or the presence of the 
peptide (data not shown). 
Next we considered the possibility that the stimula- 
tory effect of the peptide was confined to the mutant 
PLCS, isozyme. We therefore performed a series of ex- 
periments with the full-length PLCSZ protein expressed 
under similar conditions in St9 cells. Our data showed 
that the peptide (28 PM) stimulated this enzyme as well 
(not shown). 
Fig. 3 illustrates that both basal and peptide-stimu- 
lated PLC activity were absolutely dependent on and 
markedly stimulated by free Ca*‘. Furthermore, it is 
also apparent that the concentrations of free Ca*’ re- 
quired to half-maximally and maximally stimulate the 
inositol phosphate formation were similar in the ab- 
sence and in the presence of the peptide (approximately 
0.15 PM and 1 ,uM, respectively). 
1401 I 
Peptide (log M) 
Fig. 1. Stimulation of inositol phosphate formation by the peptide 
CGGLPSPEDLRGKILIKNKK. Soluble proteins (0.1 pg per tube) 
of St9 cells infected with recombinant baculovirus encoding PLC&r 
were incubated at increasing concentrations of the peptide with a 
phospholipid suspension containing PtdInsP,. See section 2 for exper- 
imental details. The incubation was performed in the presence of 
1 mM free Ca*‘. Each value represents the mean f S.D. of triplicate 
determinations. 
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Fig. 2. PLCp,-specific stimulation of insositol phosphate formation by the peptide. (A) Sf9 cells were infected as indicated with recombinant 
baculovirus encoding either B-galactosidase or PLC&l. Soluble proteins (0.1 pg per tube) were incubated as indicated in the absence (open bars) 
or the presence (hatched bars) of the peptide (28 PM) with a phospholipid suspension containing PtdInsP, (B). Soluble proteins of St3 cells infected 
with PLC&f-baculovirus were incubated at increasing protein concentrations in the absence (open symbols) or the presence (closed symbols) of 
the peptide (28 PM) with the phospholipid substrate. 
Finally, we examined the specificity of the stimula- 
tory effect of the peptide CGGLPSPEDLRGKILIKN- 
KK on PLC&l activity by comparing its effect to the 
effects of the following peptides: EQGVLPDDLSG 
(residues 116126 of G,&, VLAGSAEEGVMTPEL 
(residues 109-123 of G,&, KENLKDCGLF (residues 
341-350 of G,,), KNNLKECGLY (residues 345-354 
of GariJ) and CGGASENPFREKK (residues 5665 of 
G,,, amino-terminal cysteine and two glycines added). 
None of these peptides (in concentrations of either 28 
or 280 PM) affected the activity of PLC&l, under ex- 
perimental conditions identical to those described 
above. Note that the latter peptide is similar to the one 
under study, both at its amino- and carboxyl-terminus. 
Lysine trimer, tetramer and pentamer (28 yM) did not 
affect enzyme activity. Similarly, lysine-alanine (1: 1 and 
2: 1) and lysine-phenylalanine (1: 1) random copolymers 
(28 PM) did not enhance the inositol phosphate forma- 
tion by PLCB,d. 
4. DISCUSSION 
It has been shown by others that a peptide corre- 
sponding to a potential PtdInsP, binding site in cofilin 
binds to this phospholipid and inhibits its hydrolysis by 
various PLCs [ll]. Hence, if the sequence LPSPEDL- 
RGKILIKNKK of PLC& constitutes a PtdInsP, bind- 
ing site, then a peptide comprising the same sequence 
would be expected to compete with the enzyme for 
PtdInsP, binding, resulting in an apparent inhibition of 
its activity. Our results show, however, that such a pep- 
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tide strongly stimulates the catalytic activity of the en- 
zyme. In addition, they indicate that this stimulation is 
dependent on the presence of an active PLCB,, is not 
associated with an alteration of the Ca” affinity of this 
enzyme, and requires a defined primary and/or second- 
ary structure of the peptide (inasmuch as it could not 
be mimicked by other peptides or by amino acid oligo- 
or copolymers of basic character). 
The observed stimulation of PLCj?, may be taken to 
suggest hat the substrate is presented to the enzyme in 
a more favorable way in the presence of the peptide. 
One possibility would be that the energy threshold for 
the hydrolysis of PtdInsP, bound to the peptide is lower 
than that of free PtdInsP,. This could actually be the 
function of the basic amino acid motif in the PLC. An 
alternative explanation is that the peptide might aggre- 
gate the phospholipid substrate via its lysine residues, 
thereby facilitating the processive hydrolysis PtdInsP,. 
This possibility appears unlikely, however, due to the 
lack of effect of lysine oligo- or copolymers. 
Regarding the binding of the peptide to PtdInsP,, 
others have recently observed that the binding of a syn- 
thetic peptide corresponding to the carboxyl-terminus 
of the X domain of PLCG, and therefore rather similar 
to ours, to PtdInsP, is weak in comparison to the bind- 
ing of the intact enzyme [20]. However, in the case of 
actin-binding proteins, the corresponding peptides bind 
to PtdInsP, as strongly as the native proteins [6]. The 
reason for this discrepancy is probably that in PLCG 
there is an additional PtdInsP, binding site located at 
the amino-terminal domain, which might be responsible 
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Fig. 3. Concentration-dependence on Ca” of the stimulation of ino- 
sitol phosphate formation by the peptide. Soluble proteins (0.1 pug per 
tube) of St9 cells infected with recombinant baculovirus encoding 
PLC&t were incubated at increasing Ca*’ concentrations in the ab- 
sence (open symbols) or the presence (closed symbols) of the peptide 
(28 PM) with a phospholipid suspension containing PtdInsP,. 
for the high-affinity binding of the enzyme to its sub- 
strate [21]. The existence of such a domain in PLCS, 
deserves further investigation. 
It is also possible to envisage the stimulatory effect of 
the peptide on PLCB, as a result of a direct peptide/ 
enzyme interaction. There are many known examples of 
this type of interaction [22]. It was recently proposed, 
based on experiments with synthetic peptides, that a site 
exists on PLC, which inhibits the catalytic activity of 
this enzyme [23]. In order to explain our observations 
in a similar way we would have to postulate that PLCp2 
is under an intra- or extramolecular inhibitory con- 
straint, which can be released by the peptide. Thus, the 
peptide might exert its stimulatory effect by competing 
for binding to an inhibitory domain with a site required 
for catalytic activity. Considering the location of the 
possible inhibitory domain, we can already exclude the 
carboxyl-terminus of the enzyme, i.e. the domain which 
is necessary for stimulation by a, subunits [15], since the 
peptide stimulates a PLCj?Z mutant carrying a deletion 
in this region. 
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